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doi:10.1016/j.hkpj.2011.11.003Abstract Conventional treatment for some diseases involves a combination of pharmaco-
therapy and physiotherapy. Most of Nigeria’s training schools have introduced the course of
pharmacology in their training curriculum but its effect is still unknown. There appears to
be inadequate research on physiotherapists’ knowledge of medications in Nigeria. The primary
objectives of this study were to determine the knowledge of Nigerian physiotherapists
regarding topical pharmacotherapy and to determine the association between knowledge of
active ingredients and age, clinical experience, qualification, and work setting. A total of
135 practising physiotherapists participated in the cross-sectional survey study. A self-
administered questionnaire was used for this study. Descriptive statistics and Pearson
chi-square were used to analyse the data obtained. Only 55 respondents (40.7%) reported that
they recently updated their knowledge on topical medications; however, this contradicted the
finding that only one participant (0.7%) had very good knowledge while 57 respondents (42.2%)
have poor knowledge of the active ingredients in the topical medications listed in this study.
Also, 105 respondents (77.8%) indicated their awareness that physiotherapists can recommend
topical drugs. The results of this study revealed that some of the sampled physiotherapists
have poor knowledge about adverse reactions, contraindications, risks, and mechanisms of
action of the listed drugs, and how non-steroidal anti-inflammatory drugs relieve pain. However,
results also showed that the respondents had good knowledge (mean score of 2.46 1.03 out of
the maximum of score of 3 allotted) of the conditions in which topical medications are indicated,
although they have a poor knowledge of the common adverse reactions of topical medications
applicable in physiotherapy (mean score of 1.44 1.16 out of the maximum score of 4). A total
of 111 respondents (80.7%) could not explain how topical non-steroidal anti-inflammatory drugs
relieve pain. The results also showed that there was a significant association between years of
clinical experience and scores obtained for knowledge about active ingredients (c2Z 347.903,
p< 0.03). The study concluded that most Nigerian physiotherapists have poor knowledge ofhabilitation department, Faculty of Basic Medical Sciences, College of Health Sciences, Obafemi
e, Nigeria.
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37topical pharmacotherapy they commonly use in clinical practice. This study suggests the need to
organise continuing professional development programmes/seminars on pharmacotherapy as
applicable to physiotherapy practice to improve the knowledge base of physiotherapists.
Copyright ª 2012, Elsevier. All rights reserved.Introduction
Knowledge is the capacity to acquire, retain, and use
information. It is also a mixture of comprehension, expe-
rience, discernment, and skill [1]. Physiotherapists often
have limited knowledge or inadequate formal training in
pharmacotherapy [2]. Physiotherapy is most often used
with pharmacotherapy [3]. The recommended treatment
for a number of illnesses such as cardiac and pulmonary
diseases, diabetes mellitus, Parkinson’s disease, and rheu-
matoid arthritis involves a combination of pharmaco-
therapy and physiotherapy [4e6]. Topical pharmacotherapy
is one of the key means of treating these conditions, and
there may be an interaction between topical pharmaco-
therapy and physiotherapy intervention.
Legislation supports physiotherapists to recommend that
patients seek advice from medical practitioners or phar-
macists. It also supports the use of topical pharmaco-
therapy as an adjunct to electrophysical therapy and
manual therapy. Kumar and Grimmer [7] reported that
there is a lack of clarity regarding the need for physio-
therapists to obtain explicit consent from the patient to use
topical pharmacotherapy or to obtain information from
the patient regarding the past effects of using topical
pharmacotherapy.
Physiotherapists are often involved in direct treatment
of open wounds, using topical pharmacotherapy in
conjunction with other modalities [8]. They also frequently
advise their clients on the use of over-the-counter medi-
cations and administer them in the course of treatment [9].
This practice may have a bearing on professional liability
if side effects and contraindications are not adequately
considered. In addition, some un-prescribed topical phar-
macotherapy may have an effect on physical therapy
care [9]. There is a need for physiotherapists to have
adequate knowledge of topical pharmacotherapy such as
non-steroidal anti-inflammatory drugs (NSAIDs), analgesics,
and antibiotics, which they use frequently in administering
treatment procedures. It is also important for physiother-
apists to modify treatment programmes so as improve the
efficacy of drugs and physiotherapy [3]. This is not uncon-
nected with their knowledge [2].
The topical pharmacotherapy delivery system differs
from transdermal delivery systems; the target in the former
is a site immediately adjacent to the site of delivery rather
than using the skin as an alternate systemic delivery system
as in the case of the latter. The actions in both systems may
be on the inflammatory response itself such as decreasing
the production of inflammatory mediators or blocking the
action of inflammatory mediators, and they may act on
sensory neurons by altering the impulse generation or
through actions on specific receptors or the sensory neuron
to attenuate the activation of that neuron [10]. There are
relatively high concentrations of topical NSAIDs in thedermis, whereas levels in the muscle are at least equiva-
lent to those following systemic administration [11]. The
concentration is observed in the synovial fluid, but it is
unclear whether this reflects local penetration or results
from systemic circulation [12]. Topical capsaicin produces
benefits in post-herpetic neuralgia [13,14], diabetic
neuropathy [15], post-mastectomy pain syndrome [14,16],
oral neuropathic pain, trigeminal neuralgia, and tempro-
mandibular joint disorders [17,18], cluster headache
(following intranasal application), and dermatological and
cutaneous conditions [19]. It appears that most physio-
therapists have little or no knowledge of the pharmacody-
namics or pharmacokinetics of these drugs.
Systematic reviews of randomised trials in acute and
chronic pain have shown topical analgesics such as methyl
salicylate, capsaicin, and NSAIDs to be effective on chronic
knee osteoarthritis. To be effective, topical NSAIDs have to
penetrate the skin and either enter the circulation or
additionally be absorbed into underlying tissues to inhibit
cyclo-oxygenase. An in vitro-based index of topical anti-
inflammatory activity combines dermal penetration with
cyclo-oxygenase inhibitory effect [20].
Topical pharmacotherapeutic agents have been shown
to be effective in the management of open skin wounds.
These agents may assist in less-complicated healing and
decrease the conversion of a partial thickness injury to
a full-thickness injury, and thereby reduce wound-related
morbidity [21]. Bacitracin, a soothing ointment, is a rela-
tively inexpensive topical antimicrobial used in cleansing
small wounds (less than 10% of the total body surface area)
once or twice daily. Bacitracin, however, does not pene-
trate well and is ineffective against Gram-negative
bacteria. This may challenge the physiotherapist’s deci-
sion on the choice of bacitracin for treatment of Gram-
negative bacteria.
There appears to be a dearth of research on physio-
therapists’ knowledge of medications. Most of the related
studies emanate from Australia [2]. Also, it appears that
little or no related study has been done in Nigeria. The
primary objective of this study was to determine the
knowledge of Nigerian physiotherapists regarding several
topical pharmacotherapeutic agents. The study was also
aimed at testing the association between age, clinical
experience, qualification, and work setting, and knowledge
of the active ingredients of selected topical medications
applicable to physiotherapy.Methods
Participants and sampling
The participants comprised of 135 practising physiothera-
pists who were willing to participate in the cross-sectional
38 A.T. Onigbinde et al.survey study. These participants were selected from five
federal university teaching hospitals, two state hospitals,
one private hospital, two private clinics, and three phys-
iotherapy training schools using convenience sampling. All
work settings are in the southwest region of Nigeria. The
participants were licensed and practised at the selected
settings at the time of data collection. The participants
also willingly completed the questionnaire on the spot at
an arranged time and returned it immediately without
consulting any physiotherapy colleague or person in
a related field.
Instrumentation
A self-administered questionnaire was used for this study.
The questionnaire is a modified version of the questionnaire
used by Grimmer et al [22]. To minimise the effect of the
participants’ responses due to the variety of their educa-
tional backgrounds, the questions were kept as simple as
possible, with a Yes or No, and Don’t know response format
including free texts and checklists (of correct and incorrect
answers). The questions were influenced by some common
myths about knowledge, usage, and attitude towards
topical pharmacotherapy. The questionnaire was divided
into four sections: Demographics, Current knowledge,
Current practice, and Attitudes.
A pilot study was conducted before the actual data
collection. A draft of the questionnaire was pilot tested in
multistage phases. Ten physiotherapists who were not part
of themain studywere asked to complete the questionnaire.
This was to determine whether the questions were clear and
appropriate. On the basis of the responses, changes were
made to the questions’ layout, content, wording, and
intent. The revised questionnaire was returned to these
same physiotherapists on three different occasions until
there was no ambiguity in the questionnaire.
Research design
This study was designed as a cross-sectional exploratory
survey study.
Procedure
The Ethics and Research Committee of the Obafemi
Awolowo University Teaching Hospital Complex, Ile-Ife,
Osun State, Nigeria, granted approval for the study.
Permission was sought from the heads of the physiotherapy
department of the selected institutions to conduct the
study. The aims of the study were explained to the
participants, and confidentiality of information was
assured. A consent form was signed by all participants
ahead of the study. Two hundred copies of the question-
naire were distributed and administered to the participants
personally. In order to maintain anonymity, participant’s
name was not required in the questionnaire. The ques-
tionnaire was completed by the participating physiothera-
pists when it was convenient for them do so. The
questionnaire was completed on the spot by the partici-
pants. This was necessary to prevent the participants from
interaction and cheating. The researcher was around tosupervise the participants while they were completing the
questionnaires. In order to score the participants on
knowledge, the answers provided by the participants were
marked and graded. Sixteen was the maximum score
allotted for knowledge about active ingredients in the
checklist of the selected topical medications [Voltaren gel
(diclofenac), Feldene gel (piroxicam) (Neimeth, Lagos,
Nigeria), sprain gel (methyl salicylate) (Lagos, Nigeria),
Neurogesic ointment (methyl salicylate) (Drugfield, Lagos,
Nigeria), Lofnac cream, Zetgel (methyl salicylate), and
Urah (glucosamine sulfate) (Amber Towers, Singapore)].
Before the study, seven physiotherapists with at least 15
years of teaching experience in the physiotherapy depart-
ment of a Nigerian university were asked to grade and rate
the scores ranging from 0 (minimum) to 16 (maximum). The
consensus grading was used for rating in this study. The
respondents overall scores were graded thus:
 0e2 Very poor knowledge
 3e5 Poor knowledge
 6e8 Fair knowledge
 9e11 Good knowledge
 12e14 Very good knowledge
 Above 14 Excellent
On indications for the use of topical medications as
applicable to physiotherapy, the maximum mark was 3.
Meanwhile, the maximum mark allotted for questions on
contraindication and adverse reaction to topical medica-
tions was also 3. The maximum mark allotted to questions
on dominant charge (ion) of topical medications as appli-
cable to physiotherapy was 4.
Data analysis
Descriptive statistics (frequency, mean, and standard
deviation) was used to analyse the data obtained. Pearson
chi-square was used to test the association between scores
obtained on knowledge of active ingredients of the selected
topical medications and age, clinical experience, qualifi-
cation, and work setting. Data analysis was carried out
using statistical package for social sciences software (SPSS
Inc., Chicago, IL, USA).
Results
A total of 152 copies of the questionnaire were completed
and returned on the spot, representing a response rate of
76%. Of these, only 135 were analysed, representing an
overall response rate of 67.5%. Seventeen copies of the
questionnaire were invalidated due to the unavailability of
basic and vital information that are essential for analyses.
The results of this study showed that of the 135 respondents
in this study, 70 (51.9%) are males while 65 (48.1%) are
females. The educational qualifications attained by the
respondents and place of work are presented in Table 1.
Fifty-five respondents (40.7%) reported that they recently
updated their knowledge on topical medications, while 24
respondents (17.8%) reported that they had never updated
their knowledge on topical medications. Fifty-two (40.9%)
of the 134 respondents reported that they did not seek
Table 1 Respondents’ demographic profile
Variable Frequency Percentage c2 p
Highest qualification
Bachelor’s degree 66 49.3
Master’s degree 52 38.8
Doctorate 17 11.9 33.2 <0.001
Experience
1e5 y 46 34.1
6e11 y 44 32.5
12e17 y 23 17.1
18e23 y 18 13.3
24e29 y 4 3.0 93.9 <0.001
Work place
Private hospital 16 11.9
State hospital 6 4.4
Teaching hospital 70 51.9
Academic setting 17 12.6
Any three of
the above
5 3.7
Others 21 15.6 10.6 0.010
Table 2 Current work schedules, update of knowledge,
source of information
Variable Frequency
(nZ 135)
Percentage c2 p
Current work time
In-patients 49 36.3
Private practice 23 17.0
Out-patients 37 27.4
Community setting 4 3.0
Others 22 16.3 4.1 0.260
Update of knowledge
Never 24 17.8
Recently 55 40.7
<1 y 25 16.3
1e5 y 16 11.85
5e10 y 11 8.15
>10 y ago 4 3.0 2.3 0.500
Information seeking
Yes 75 59.1
No 52 40.9 4.2 0.040
Source of information (multiple choice)
Drug companies 80 59.3
Journal articles 49 36.3
Advertising 36 26.7
Via another
physiotherapist
30 22.2
Training schools 20 14.8
Local pharmacist 19 14.1
Via EMDEX 18 13.3
General medical
practitioners
15 11.1
Others 8 5.9
Via NSP 5 3.7
Via MRTB seminars 2 1.5 d d
EMDEXZ Electric and Magnetic Field Digital Exposure System;
MRTBZMedical Rehabilitation Therapists Registration Board of
Nigeria; NSPZ Nigeria Society of Nigeria.
Table 3 Frequency distribution of knowledge on active
ingredients in topical medications
Range
of score
Grading Frequency
(nZ 135)
Percent
0e2 Very poor knowledge 18 13.5
3e5 Poor knowledge 57 42.2
6e8 Fair knowledge 48 35.5
9e11 Good Knowledge 11 8.1
12e14 Very good knowledge 1 0.7
14 and above Excellent 0 0
39for information to update their knowledge on topical
medications applicable to physiotherapy. The results also
showed that the most common source (59.3%) used to
update knowledge about topical medications is through
seminars given by drug companies. (Multiple answers were
provided to these questions, as shown by the total number
of responses; see Table 2.)
The result of the chi-square test showed that there was
a significant difference in the percentage difference in the
number of respondents across the categories of degrees of
qualifications, years of clinical experience, and work
settings (c2Z 33.2, p< 0.001, c2Z 93.9, p< 0.001, and
c2Z 10.6, pZ 0.010, respectively; Table 1). Similarly, the
number of respondents who sought to improve their
knowledge was significantly higher than those who did not
(c2Z 4.2, pZ 0.040). However, there was no significant
difference in the percentage difference in the number of
respondents’ current work time and duration of when
knowledge was last updated (Table 2). The mean score of
respondents with regard to knowledge of the active ingre-
dients in topical medications commonly used in physio-
therapy was 5.21 2.52 out of a maximum score of 16. Only
one participant (0.7%) had a very good knowledge of the
active ingredients in topical medications listed in this
study, while 57 respondents (42.2%) had poor knowledge
(Table 3).
Out of the 146 responses (multiple choices) to the
question on risk associated with the use of topical medi-
cations as applicable in physiotherapy, 80 respondents
(5.9%) indicated rashes, 19 respondents (14.1%) indicated
itching, five respondents (3.7%) indicated burns, while
other risks were indicated by 28 respondents (20.7%).
Eighteen respondents (13.3%) gave incorrect answers, while
68 respondents indicated that there is no risk.
The results of the study showed a significant association
between years of clinical experience and scores obtained
for knowledge about active ingredients (c2Z 347.9,
pZ 0.030). However, there was no significant associationbetween age, place of work (work setting), and qualifica-
tion (Table 4).
On the question of whether legislation allows physio-
therapists to advise on the use of topical medications as
applicable in physiotherapy, 95 respondents (70.4%) indi-
cated “Yes”, eight respondents (5.9%) indicated “No”,
while 32 respondents (23.7%) reported “Don’t know”. When
Table 4 Association of knowledge about active ingredi-
ents with age, years of clinical experience, qualifications
and work setting
Variables c2 Degree
of freedom
p
Age 40.6 36 0.070
Years of clinical experience 347.9 348 0.030
Qualifications 4.0 3 0.490
Places of work (work setting) 75.6 60 0.140
Table 6 Knowledge of physiotherapists on selected
topical antibiotics used in wound management
Variable Yes No Don’t know
n % n % n %
Gentamicin 45 34.3 5 3.7 83 61.5
Bacitracin 33 24.6 6 4.5 95 70.3
Neomycin 26 19.4 4 3.0 104 77.0
Silver sulfadiazine 28 20.7 6 4.4 110 81.5
Mafenide acetate 17 12.6 8 5.9 110 81.5
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allows physiotherapists to prescribe topical medications as
applicable to physiotherapy, 105 respondents (77.8%) indi-
cated “Yes”, seven respondents (5.2%) indicated “No”,
while 23 (17.0%) indicated “Don’t know”. Other results on
permission to recommend, supply, and use topical medi-
cation as applicable to physiotherapy are presented in
Table 5.
When respondents were asked to list three conditions
for which topical medications are used as applicable to
physiotherapy, the result showed that the respondents
had a mean score of 2.46 1.03 out of the maximum of
score of 3. When asked to list three conditions for which
topical medications are contraindicated as applicable to
physiotherapy, the results revealed that the respondents
had a mean score of 1.28 1.13 out of the maximum
score of 3. On common adverse reactions of topical medi-
cations applicable in physiotherapy, the mean score was
1.44 1.16 out of the maximum score of 4.
Respondents were asked to state how topical NSAIDs
relieve pain. Out of 134 respondents, 18 respondents
(13.4%) indicated that they inhibit the production of cyclo-
oxygenase, three respondents (2.2%) indicated that they
deactivate nociceptive nerves through cooling, two
respondents (1.5%) gave relevant mode of actions, while
the other 111 respondents (80.7%) gave incorrect answers.
Regarding the knowledge of respondents about topical
antibiotic drugs that are applicable in wound management
as related to physiotherapy, the results showed that for
Gentamicin ointment, 83 respondents (61.5%) reported that
they do not know if it is applicable; this is similarly
reflected in the other listed topical antibiotics (Table 6).
Respondents were asked to provide in free text what
they understood by iontophoresis. Out of 135 respondents,
74 respondents (55.6%) answered correctly, while 59
respondents (44.4%) answered incorrectly. Similarly, whenTable 5 Advise, prescription, and use of topical medications
Yes
n
Advise on the use of topical medications 95
Prescription of topical medications 101
Recommend topical medications 109
Supply topical medications 30
Use topical medications 113
nZ frequency, %Z percentage.respondents were asked what they understood by phono-
phoresis, 70 respondents (57.8%) answered correctly while
63 respondents (46.7%) answered incorrectly. To corrobo-
rate the questions on iontophoresis, respondents were
asked to identify the dominant ions present in some
selected topical medications as applicable to physio-
therapy. The results showed that the mean score on
knowledge was 0.60 1.30 out of the maximum score of 4.
This showed that most of the respondents have a very poor
knowledge of the mechanism of iontophoresis.
Discussion
This study showed that a significant percentage of the
respondents have a basic first degree qualification and
a few years of clinical experience ranging between 1 and 11
years, and these may be contributory factors to the poor
level of knowledge observed in this study. Contrarily,
a significant percentage reported that they sought for
knowledge on pharmacotherapy while a significant number
of respondents were working in a university teaching
hospital; if so, this was not a true reflection of the poor
level of knowledge observed about active ingredients,
adverse reactions, contraindications, risks, mechanism of
action of how NSAIDs relieve pain, and dominant ions of
topical drugs used for iontophoresis. However, most
respondents actively sought for information to update their
knowledge from seminars offered by drug companies and
from journal articles, although they also noted that in the
past 6 months they mostly used instructions from medica-
tion packets. This varied from previous findings in Australia,
where physiotherapists mostly updated their knowledge
between 1 and 5 years, and their most common source of
information was the Monthly Index of Medical Specialties
and medical practitioners [9,22].No Don’t know
% n % n %
70.4 8 5.9 32 23.7
77.8 7 5.2 2 17.0
80.7 5 3.7 21 15.6
22.2 8 5.9 32 23.7
83.7 3 2.1 19 14.1
41This study suggests that there is need for continuing
professional development seminars on the quality use of
topical medicines. Academic curriculum should also be
reviewed to include topical pharmacotherapy for under-
graduate physiotherapy students. The results of this study
showed that the overall mean score of the sampled phys-
iotherapists reflects that they have a poor knowledge of
the active ingredients in topical medications which they
frequently use. Majority of the respondents opined that
there was no risk associated with the use of topical medi-
cations in physiotherapy practice. This supports the
previous findings that physiotherapists lack knowledge on
topical medications, which have similar risks as oral medi-
cations [9]. This is corroborated by the findings that the use
of topical methyl salicylate ointments in cardiac disease
patients receiving anticoagulation therapy could portend:
a risk of bleeding manifestation, bruises in the skin, and
gastrointestinal bleeding [23].
This study further revealed that respondents have a very
low mean score in knowledge on contraindication of the
selected topical medications listed in the study. Survey
studies emanating from Australia showed that many phys-
iotherapists reported inadequate training on medications
[2]. These accounted for some lax practices such as failing
to keep comprehensive records or making only occasional
inquiries about medications. Grimmer et al [22], in a similar
study, reported that few physiotherapists responded to
questions regarding the side effects of topical NSAIDs. Yip
et al [24] observed that topical methyl salicylate caused
local irritation, dermatitis, local burn injuries, skin redness,
and various degrees of pain after about an hour of appli-
cation. They advised that people be aware of its potential
risk. The adverse effect of topical capsaicin is burning pain
at the site of application. Topical lidocaine as a 5% gel or
patch [25,26] provides effective pain relief in post-herpetic
neuralgia with no systemic adverse effects. This study
showed that most respondents do not understand how
NSAIDs relieve pain. This supports the findings of Grimmer
et al [22], who reported that majority of Australian phys-
iotherapists believed that topical NSAIDs are placebos, and
hence they do not understand the mechanism of action of
the topical medications they use. This further supports the
findings of Lansbury and Sullivan [9], who raised concerns
about physiotherapists advising and administering medica-
tions (especially topical medicationsdover the counter) to
their clients despite having limited knowledge about the
appropriateness, side effects, and contraindications of
specific medications they use in clinical practice.
This study found no association between knowledge of
active ingredients in topical medications and age, academic
qualifications, and clinical settings. The common clinical
settings where Nigerian physiotherapists practice are
university teaching hospitals, state hospitals, academic
setting, private clinics, and sports medicine centres. The
university teaching hospital appears to have the highest
standards in terms of quality personnel, equipment, and
facilities. The pay or financial remuneration received by
physiotherapists who work there is also higher compared to
that earned by their counterparts in other settings, except
in the case of a few physiotherapists in sports medicine
centres who earn extra allowances from sports trips.
However, there was a significant association between yearsof clinical experience and knowledge. This tends to confirm
the usual assumption that clinicians with more experience
in general have accumulated knowledge and skills during
years in practice and therefore may be able to deliver
high-quality care. However, among physicians, evidence
suggests that there is an inverse relationship between the
number of years that a physician has been in practice and
the quality of care that he provides [27].
Overall, the results of this study revealed that a large
number of physiotherapists have knowledge of conditions
in which topical medications are indicated. This falls in
line with the results of a previous study [22]. In addition,
the high percentage of “Don’t know” and incorrect
responses on legislation, advise, prescription, recommen-
dation, supply, and use of topical medications indicated
that there is need for more education for physiotherapists
because it is their responsibility to have knowledge of what
they recommend and prescribe in clinical practice.References
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